Total Payments
$740.84
2024 Payments
$189.14
Companies
9
Transactions
16
Medicare Patients
793
Medicare Billing
$74,606
Payment Breakdown by Category
Food & Beverage$725.54 (97.9%)
Education$15.30 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $725.54 | 15 | 97.9% |
| Education | $15.30 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $209.18 | 4 | $0 (2019) |
| AMAG Pharmaceuticals, Inc. | $130.68 | 2 | $0 (2019) |
| Antares Pharma, Inc. | $123.83 | 1 | $0 (2022) |
| Novo Nordisk Inc | $118.30 | 1 | $0 (2024) |
| PAINTEQ LLC | $70.84 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $39.64 | 2 | $0 (2017) |
| Relievant Medsystems, Inc. | $24.44 | 1 | $0 (2022) |
| Boston Scientific Corporation | $12.82 | 1 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $11.11 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $189.14 | 4 | Novo Nordisk Inc ($118.30) |
| 2022 | $148.27 | 2 | Antares Pharma, Inc. ($123.83) |
| 2019 | $305.37 | 4 | AbbVie, Inc. ($177.17) |
| 2017 | $98.06 | 6 | AstraZeneca Pharmaceuticals LP ($39.64) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $118.30 | General |
| 02/22/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/18/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/17/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/14/2022 | Relievant Medsystems, Inc. | Intracept (Device), Intracept | Food and Beverage | Cash or cash equivalent | $24.44 | General |
| Category: Pain | ||||||
| 08/04/2022 | Antares Pharma, Inc. | TLANDO (Drug) | Food and Beverage | In-kind items and services | $123.83 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/14/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $98.69 | General |
| Category: Endocrinology | ||||||
| 08/28/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $78.48 | General |
| Category: Endocrinology | ||||||
| 04/11/2019 | Boston Scientific Corporation | SYMPHION (Device) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: GYNECOLOGY | ||||||
| 04/02/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $115.38 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 10/09/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $15.30 | General |
| Category: INTRAROSA | ||||||
| 03/27/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/25/2017 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Endocrinology | ||||||
| 02/13/2017 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Endocrinology | ||||||
| 01/09/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Lower GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 218 | 261 | $66,337 | $20,512 |
| 2022 | 7 | 249 | 290 | $61,822 | $20,467 |
| 2021 | 6 | 184 | 209 | $56,602 | $20,455 |
| 2020 | 7 | 142 | 162 | $33,259 | $13,171 |
Total Patients
793
Total Services
922
Medicare Billing
$74,606
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 78 | $24,882 | $7,505 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 78 | $16,848 | $5,309 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 18 | $7,650 | $2,473 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,628 | $1,891 | 33.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $6,210 | $1,852 | 29.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,495 | $601.25 | 40.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $2,090 | $591.30 | 28.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 26 | $1,534 | $289.75 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 89 | $17,622 | $5,918 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 55 | $16,170 | $5,119 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $10,875 | $3,806 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 21 | $8,232 | $2,561 | 31.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 38 | $3,990 | $1,689 | 42.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 19 | 19 | $3,458 | $1,088 | 31.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 25 | $1,475 | $286.68 | 19.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 58 | $17,052 | $6,138 | 36.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 56 | $10,789 | $4,176 | 38.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 24 | $9,400 | $3,430 | 36.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 37 | 37 | $9,213 | $3,292 | 35.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $7,600 | $2,560 | 33.7% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 14 | 14 | $2,548 | $858.62 | 33.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 41 | $9,063 | $3,315 | 36.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 29 | 38 | $6,536 | $3,188 | 48.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 18 | $5,368 | $1,938 | 36.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $3,991 | $1,491 | 37.4% |
About Dr. Robert Howe, MD
Dr. Robert Howe, MD is a Reproductive Endocrinology healthcare provider based in E Longmeadow, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689651614.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Howe, MD has received a total of $740.84 in payments from pharmaceutical and medical device companies, with $189.14 received in 2024. These payments were reported across 16 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($725.54).
As a Medicare-enrolled provider, Howe has provided services to 793 Medicare beneficiaries, totaling 922 services with total Medicare billing of $74,606. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Reproductive Endocrinology
- Other Specialties Gynecology, Diagnostic Ultrasound
- Location E Longmeadow, MA
- Active Since 12/30/2005
- Last Updated 04/24/2009
- Taxonomy Code 207VE0102X
- Entity Type Individual
- NPI Number 1689651614
Products in Payments
- Orilissa (Drug) $177.17
- INTRAROSA (Drug) $130.68
- TLANDO (Drug) $123.83
- PAINTEQ (Device) $70.84
- FARXIGA (Drug) $39.64
- Intracept (Device) $24.44
- Lupron (Drug) $20.99
- SYMPHION (Device) $12.82
- Amitiza (Drug) $11.11
- Synthroid (Drug) $11.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.